Kidney transplantation is the most frequently performed organ transplant procedure in the world. The occurrence of malignant tumors is one of the well-known late complications of organ transplantation, which is induced by immunosuppressive therapy. In the vast majority of patients, kidney cancer occurs in the native organs; however, in a small percentage of cases, malignancies are found in the graft organ. The article describes a rare clinical case of a patient with synchronous cancer in the native and graft kidneys
Immunosuppression is a well-known risk factor for malignancy. Renal transplant patients are at high ...
The development of malignancies is a relevant long-term complication of organ transplantation. Carci...
The aim of our study is to determine characteristics and outcomes of kidney cancer in renal transpla...
Malignancies are one of the leading causes of death in long-term surviving transplant recipients. Do...
Malignancies are one of the leading causes of death in long-term surviving transplant recipients. Do...
Cancer in the transplanted kidney is rare, and its clinical and surgical management can be controver...
Journal Article;The incidence of malignant tumors in recipients of renal allografts is higher than i...
Journal Article;The incidence of malignant tumors in recipients of renal allografts is higher than i...
Journal Article;The incidence of malignant tumors in recipients of renal allografts is higher than i...
Malignancy is an important cause of mortality and morbidity after solid organ transplantations. In a...
This paper presents the first case of a kidney graft recipient with double malignancy of the upper u...
The most prevalent skin cancer in the transplant organ recipients is squamous cell cancer, followed ...
With the rising incidence of end-stage renal disease in the United States, patients needing renal tr...
Copyright © 2015 Amudha Palanisamy et al. This is an open access article distributed under the Creat...
Abstract Background Kidney transplantation (KT) is the treatment option for patients with end stage ...
Immunosuppression is a well-known risk factor for malignancy. Renal transplant patients are at high ...
The development of malignancies is a relevant long-term complication of organ transplantation. Carci...
The aim of our study is to determine characteristics and outcomes of kidney cancer in renal transpla...
Malignancies are one of the leading causes of death in long-term surviving transplant recipients. Do...
Malignancies are one of the leading causes of death in long-term surviving transplant recipients. Do...
Cancer in the transplanted kidney is rare, and its clinical and surgical management can be controver...
Journal Article;The incidence of malignant tumors in recipients of renal allografts is higher than i...
Journal Article;The incidence of malignant tumors in recipients of renal allografts is higher than i...
Journal Article;The incidence of malignant tumors in recipients of renal allografts is higher than i...
Malignancy is an important cause of mortality and morbidity after solid organ transplantations. In a...
This paper presents the first case of a kidney graft recipient with double malignancy of the upper u...
The most prevalent skin cancer in the transplant organ recipients is squamous cell cancer, followed ...
With the rising incidence of end-stage renal disease in the United States, patients needing renal tr...
Copyright © 2015 Amudha Palanisamy et al. This is an open access article distributed under the Creat...
Abstract Background Kidney transplantation (KT) is the treatment option for patients with end stage ...
Immunosuppression is a well-known risk factor for malignancy. Renal transplant patients are at high ...
The development of malignancies is a relevant long-term complication of organ transplantation. Carci...
The aim of our study is to determine characteristics and outcomes of kidney cancer in renal transpla...